The CNPV pilot program approved its first drug, an amoxicillin-clavulanate potassium antibiotic, in two months, enhancing domestic manufacturing and national security. Augmentin XR, combining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback